RSS
patent expiration
Otsuka, Eli Lilly, and AstraZeneca to lose out in patent cliff
Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent expiries of several leading drugs, according to research and consulting firm GlobalData. Read more
Sanofi facing triple threat from Eli Lilly for diabetes treatment market space
The imminent patent expiration of Sanofi’s Lantus has opened the door for Eli Lilly to increase its share of the diabetes treatment market Read more
